Next, to discover statistically significant genes recurrently mutated above background rates, we applied MutSig2CV23, 24 independently to cfDNA and tumor biopsies and identified ESR1, TP53, PIK3CA, ARID1A (Fig. 3a, Supplementary Data 8). The gene discussed is ARID1A; the disease is neoplasm.